Simris Alg signs agreement on research collaboration

Report this content

Simris Alg AB (publ) has entered a five-year agreement with Anhalt University of Applied Sciences in Germany (AUAS) for the development of novel biologically active substances from microalgae for advanced skincare. The research on microalgae at AUAS is led by Prof. Dr. Claudia Grewe, who has over ten years of industry experience from leadership positions in research, development and production. The collaboration increases Simris Alg's R&D capacity and aims to accelerate product development within the company’s Simris Biomimetics business area.

ABOUT SIMRIS BIOMIMETICS
Simris Biomimetics, together with Simris Novel Foods and the consumer brand SIMRIS®, is one of Simris Alg's three business verticals. Simris Biomimetics is devoted to
research, development and commercialisation of substances and extracts from microalgae for applications in advanced skincare and bio-based pharmaceuticals. The business targets a global and growing market for biotechnological specialty ingredients worth over USD 500 million (2019). The first products are expected to reach the market in 2022.

ABOUT ANHALT UNIVERSITY OF APPLIED SCIENCES (AUAS)
AUAS is a German university of applied sciences with three campuses in Köthen, Bernburg and Dessau. The university offers academic education for about 7,000 undergraduate and graduate students at seven different departments. In all departments, scientific research is conducted in cooperation with regional, national and international partners. 

FOR MORE INFORMATION, PLEASE CONTACT:
Fredrika Gullfot, CEO Simris
Tel: +46 761 345 474, email: gullfot@simris.com

ABOUT SIMRIS ALG AB (PUBL)
Simris Alg 
is a multi-awarded pioneer business developing bioactive substances from algae. The company's purpose and business is to save endagered marine habitats by producing raw materials from microalgae, instead of fish and other marine animals. Simris operates in three business areas: SIMRIS BIOMIMETICS (skincare and pharmaceuticals), SIMRIS NOVEL FOODS (new dietary ingredients), and the SIMRIS consumer brand targeted to the global lifestyle, beauty and wellness markets. Simris Alg's shares are traded on the Nasdaq First North Growth Market with ticker SIMRIS and ISIN SE0008091664. Certified Adviser is Mangold Fondkommission AB, phone +46 (0)8-503 015 50 and email ca@mangold.se.

Tags:

Media

Media

Documents & Links